<DOC>
	<DOCNO>NCT00648141</DOCNO>
	<brief_summary>To compare safety efficacy once-daily twice-daily celecoxib versus diclofenac treatment ankylose spondylitis</brief_summary>
	<brief_title>Safety Efficacy Celecoxib Versus Diclofenac Treatment Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Diagnosis ankylose spondylitis define accord modified New York criterion , axial involvement Requiring daily treatment nonsteroidal antiinflammatory drug previous 30 day Patients inflammatory enterophathy , extraarticular manifestation Patients know vertebral compression Received corticosteroid 6 week prior baseline visit ; patient stable dose prednisolone equivalent â‰¤ 10 mg/ day least 14 day randomization permit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>